Global Pathology AI (Artificial Intelligence) market Report from The Delvens highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns country along with competitive landscape, Key Competitors market shares, and strategies that are key to the Global market. In addition, the study helps venture or private players in understanding the companies in more detail to make better informed decisions.
The global Pathology AI (Artificial Intelligence) market size was estimated at USD 23.4 million in 2023 and is projected to reach USD 66.53 billion in 2030 at a CAGR of 16.1% during the forecast period 2023-2030.
Get Free Sample Report@ https://www.delvens.com/get-free-sample/pathology-ai-market
The AI Pathology Market can be defined as the integration of AI-based algorithms and machine learning techniques in the world of pathology. Pathology, a critical discipline in medicine, involves the study of tissues and cells to diagnose diseases, understand their progression, and guide treatment decisions. With the advent of artificial intelligence, this traditional practice is undergoing a profound transformation, supported by advanced computing capabilities that provide pathologists and healthcare providers with unprecedented insights.
Increasing government initiatives to encourage healthcare providers and other healthcare organizations to adopt AI-based diagnostic technologies, as well as investments by non-profits and private companies for better data sharing, improved clinical outcomes and cost reduction are some of the expected key drivers. to boost the growth of the artificial intelligence pathology market during the forecast period. Additionally, high demand for e-diagnosis services in healthcare due to increasing government healthcare expenditure is fueling the market growth.
Competitive Landscape
- General Electric Co. (GE Healthcare)
- Koninklijke Philips N.V
- Hoffmann-La Roche Ltd
- Hologic, Inc
- Akoya Biosciences, Inc
- Aiforia
- Indica Labs Inc
- OptraScan
- Ibex Medical Analytics Ltd.
- Mindpeak GmbH
- Tribun Health
- Siemens Healthineers
- Zebra Medical Vision, Inc.
- Riverain Technologies
- IDx Technologies Inc.
- NovaSignal Corporation
- Vuno, Inc.
- Aidoc
- Neural Analytics
- Imagen Technologies
- Digital Diagnostics, Inc.
- GE Healthcare
- AliveCor Inc.
- Proscia Inc
- PathAl, Inc.
- Tempus Labs, Inc.
For More Inquiry Contact us@ https://www.delvens.com/Inquire-before-buying/pathology-ai-market
Recent Developments
- In April 2023, Indica Labs Inc. signed an agreement with Lunit Inc. The agreement helped to provide a fully interoperable solution between Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.
- In March 2022, Ibex Medical Analytics Ltd. Had partnered with Dedalus Group. Through this partnership, the company aimed to bring the power of artificial intelligence to digital pathology.
North America to Dominate the Market
- North America is estimated to account for the largest market share during the forecast period. In North America, there is growing investments and reforms to modernize the pathology infrastructure in the region and the increasing adoption of digital pathology solutions.
- Moreover, the expansion of healthcare infrastructure and growing market availability of advanced AI technologies.
Regional Level Scope
- North America,
- Europe,
- Asia-Pacific,
- South America, and
- Middle East, and Africa
Reasons to Acquire
- Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
- Gain authentic and granular data access for the Pathology AI (Artificial Intelligence) Market to understand the trends and the factors involved in changing market situations.
- Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
Access Full Report@ https://www.delvens.com/report/pathology-ai-market
In addition to the market data for the Pathology AI (Artificial Intelligence) market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
Browse Full Report@
Antacids market size was estimated at USD 7.3 billion in 2023 and is projected to reach USD 10.30 billion in 2030 at a CAGR of 5.04% during the forecast period 2023-2030.
Antibody Drug Conjugates (ADC) market size was estimated at USD 5.78 billion in 2023 and is projected to reach USD 24.53 billion in 2030 at a CAGR of 22.94% during the forecast period 2023-2030.
Non-Small Cell Lung Cancer (NSCLC) market size was estimated at USD 15.1 billion in 2023 and is projected to reach USD 28.3 billion in 2030 at a CAGR of 9.40% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT Telecom, Chemicals Materials, Semiconductor Electronics, Energy, Pharmaceutical, Consumer Goods Services, Food Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
